Molecular Glues Market Size, Share & Industry Analysis, By Product (Thalidomide, Lenalidomide, Pomalidomide, and Others), By Application (Hematologic Malignancies, Solid Tumors, Autoimmune & Inflammatory Diseases, Neurological & Genetic Diseases, and Others) By Type (CRBN/Cereblon-based Molecular Glues, DCAF15-based Molecular Glues, Novel E3 Ligase-based Molecular Glues, and Others), By End User (Pharmaceutical & Biotechnology Companies, CROs/Drug Discovery Service Providers, Academic & Research Institutes, and Others), and Regional Forecast, 2026-2034

Last Updated: July 02, 2026 | Format: PDF | Report ID: FBI117900

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 7.09% from 2026-2034
Unit	Value (USD Billion )
Segmentation	By Product, Application, Type, End User, and Region
By Product	Thalidomide Lenalidomide Pomalidomide Others
By Application	Hematologic Malignancies Solid Tumors Autoimmune & Inflammatory Diseases Neurological & Genetic Diseases Others
By Type	CRBN/Cereblon-based Molecular Glues DCAF15-based Molecular Glues Novel E3 Ligase-based Molecular Glues Others
By End User	Pharmaceutical & Biotechnology Companies CROs/Drug Discovery Service Providers Academic & Research Institutes Others
By Region	North America (By Product, Application, Type, End User, and Country) U.S. Canada Europe (By Product, Application, Type, End User, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Product, Application, Type, End User, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Product, Application, Type, End User, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Product, Application, Type, End User, and Country/Sub-region) GCC South Africa Rest of Middle East & Africa